Purespring

Purespring Therapeutics

This company develops gene therapies for patients with chronic renal diseases to preserve kidney function and treat conditions like IgA nephropathy.

Nionyx Bio

The company develops adeno-associated virus gene therapies for patients with genetic kidney diseases.

Nephrogen

This biotechnology company develops artificial intelligence-driven gene therapies to treat kidney and pancreatic diseases for patients with genetic conditions.

Estuary Biotherapeutics

This biotechnology company develops targeted genetic medicines for patients with serious kidney conditions, specifically autosomal dominant polycystic kidney disease.

Chinook Therapeutics

This biopharmaceutical company develops precision medicines for patients with rare and severe chronic kidney diseases.

Trestle Biotherapeutics

This company develops implantable bioengineered kidney tissues to restore renal function for patients suffering from end-stage renal disease.

Veratx

The company develops medicines for patients with autoimmune diseases, focusing on the treatment of kidney conditions such as IgA nephropathy.

River Renal

This clinical-stage biotechnology company develops novel pharmaceutical therapies targeting orphan renal diseases for patients with unmet medical needs.